Login Register
Follow Us

Indian vaccine has shown ‘least side-effects’

Phase III trials of Covaxin begin at Rohtak today

Show comments

Rohtak, November 18

India is going to be amongst the pioneering nations of the world with the development of its indigenous Covid vaccine Covaxin in the near future. Indian Covid-19 vaccine is unique as it has shown minimum side-effects.

This was stated by Dr OP Kalra, Vice Chancellor of Pt Bhagwat Dayal Sharma University of Health Sciences, Rohtak, while addressing a news conference here today.

Professor Kalra disclosed that the third phase of the clinical human trials of Covaxin would begin at the Rohtak PGIMS on November 19. — TNS

Show comments
Show comments

Trending News

Also In This Section


Top News



Most Read In 24 Hours